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Expression of estrogen receptors (ER)- and - , as well α β
as androgen receptor (AR), in hepatocellular carcinoma
(HCC) is thought to be correlated with prognosis, survival,
and male prevalence of HCC. These hypotheses are based
on investigations of European patients; however the ex-
pression patterns of these receptors in Asian patients are
largely unknown. In this study, we collected liver carcinoma
and peritumor tissues from 32 patients (9 females and 23
males) in South Korea. The expression of ERs and ARs
was studied using RT-PCR. Wild-type ER- and AR were α
expressed in all of the samples investigated, and their ex-
pression was independent of the causal virus or patient sex.
Expression of the ER- variant was independent of sex α
(100% female vs. 91.3% male) and HCV and HBV status
(91.3% vs. 100%). Wild-type ER- was expressed more β
often in HCV patients than in HBV patients (95.7% vs.
44.4%; p < 0.05). In conclusion, the stronger ER- variant α
expression in HCC tissues implies that this variant has an
important role in HCC development. However, at least in
Korean patients, expression of the ER- variant (vER- ) is α α
not related to male HCC prevalence. In addition, the pre-
dominant expression of ER- in HCV patients suggests tha β t
it plays an important role in HCV-induced liver disease.
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INTRODUCTION
The liver is a hormone-sensitive organ. Although
sex hormones function in sexual organs, such as
the breast,
1 they also affect many mammalian liver
functions.
2,3 Both male and female livers contain
androgen receptors,
4-6 as well as high-affinity,
low-capacity estrogen receptors.
7,8 Several lines of
evidence suggest that sex hormones and their
receptors play a role in liver carcinogenesis.
9
Clinical studies have shown that men are more
prone to developing hepatocellular carcinoma
(HCC) than women. Furthermore, studies have
also shown that androgens might be involved in
malignant liver transformation.
10 Some reports
have shown that, in HCC, estrogen receptor level
decreases, while androgen receptor level in-
creases.
11 In addition, HCC tissues may take up
testosterone actively,
12 Elevated serum testos-
terone levels increase the risk of HCC,
13 and male
sex is one of the most prominent HCC risk
factors.
9 Individuals with AR-negative tumors had
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a 55% survival rate five years after surgery, while
those with AR-positive tumors had a 0% survival
rate.
14
Conversely, estrogen also promotes hepatocar-
cinogenesis.
9 Specifically, Villa et al.
15 first re-
ported the ER- variant in human primary HCC α
tissues. The variant ER (vER)- was also signifi α -
cantly associated with the male sex. Recently,
Iavarone et al.
16 reported vER- in liver diseases. β
In addition, ER- was found to be significantly β
expressed in HCV-infected patients. This evidence
implies that the expression of ERs and their vari-
ants plays a role in the progress of hepatocarcino-
genesis and is associated with the male prevalence
of HCC, as well as with specific viral infections.
However, these studies were all conducted in
European countries. Although, in Asia, HCC con-
stitutes 30-40% of human tumors, the expression
patterns of AR and ERs in Asian HCC patients are
still largely unknown.
HCC is one of the most prevalent malignant
tumors in Korea.
17 Therefore, we investigated the
expression of AR and ERs in HCC patients from
South Korea. In this study, we describe the dif-
ferent expression patterns of sex hormone receptors
that are associated with HCC.
MATERIALS AND METHODS
Patients
We investigated 32 primary HCC tumors and
adjacent peritumor tissues which were obtained
from patients at the Catholic University of Korea
(Dept. of Internal Medicine, Seoul, Korea), the
Korea Institute of Radiological and Medical
Sciences (Molecular Oncology laboratory, Seoul,
Korea), the Ajou University School of Medicine
(Dept. of Surgery, Suwon, Korea), the Chungnam
National University College of Medicine (Dept. of
Pathology, Daejeon, Korea), and the Yeungnam
University College of Medicine (Dept. of Bioche-
mistry & Molecular Biology, Daegu, Korea). The
clinical features of the enrolled patients are de-
scribed in Table 1. The tissue samples were
snap-frozen and stored in liquid nitrogen until the
RNA was extracted. Sixty-four samples were an-
alyzed in total.
ER and AR assay
Primers were designed from published gene
sequences (Table 2). When designing the primers,
particular attention was paid to the high homology
Table 2. The Primers and RT-PCR Product Size for the Genes Investigated
Gene name Forward primers Reverse primers Wt Vt
AR 5’-AAGGAACTCGATCGTATCATTGC-3’ 5’-AATAGATGGGCTTGACTTTCCCA-3’ 241 bp
ER- (1) α 5’-GGAGACATGAGAGCTGCCAAC-3’ 5’-CCAGCAGCATGTCGAAGATC-3’ 439 bp 300 bp
ER- (2) α 5’-CACAAGCGCCAGAGAGATGA-3’ 5’-CATCATGCGGAACCGAGATG-3’ 516 bp 377 bp
ER- (1) β 5’-TCACTTCTGCGCTGTCTGCAGCG-3’ 5’-CCTGGGTCGCTGTGACCAGA-3’ 818 bp 679 bp
ER- (2) β 5’-GGCCAAGAGAAGTGGCGGCCACG-3’ 5’-AAACCTTGAAGTAGTTGCCAGGAGC-3’ 430 bp 291 bp
ER- (3) β 5’-GCTGGGCCAAGAAGATTCCCG-3’ 5’-GTGACCAGAGGGTACATACTGG-3’ 313 bp 174 bp
GAPDH 5’-GAAGGTGAAGGTCGGAGTC-3’ 5’-GAAGATGGTGATGGGATTTC-3’ 230 bp
Wt, wild type; Vt, variant type; AR, androgen receptor; ER, estrogen receptor.
Table 1. Epidemiological and Clinical Features of the 32 Patients Enrolled in the Study
No. of patients Sex (M : F) Age (yrs)
HCV patients 23 16 : 7 65 ± 8
HBV patients 9 7 : 2 56 ± 8
No., number; yrs, years.ER Expression in Korean HCC Patients
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between ER- and ER- . Specifically, the primer α β
pair for ER- was located in exons 4 and 6 α
18 in
order to amplify a possible exon 5 deletion. The
primer pair for ER- was located in exons 2 and β
7.
19 The GAPDH, AR, and additional ER- primers β
were designed by our laboratory and checked on
human cell lines to ensure that the products of the
primers were the correct size and produced only
a single band.
RT-PCR was performed to detect AR and ER
expression in human HCC and related, adjacent
peritumor tissues. The RT step was carried out
using a Reverse Transcription kit (Promega,
Madison, WI, USA), according to the manufac-
turer's instructions. The PCR step was performed.
using AccPrime
TM Taq DNA polymerase
(Invitrogen, Carlsbad, CA, USA) per the manufac-
turer's instructions. Four micrograms of total RNA
were reverse transcribed into cDNA. Ap-
proximately 4-5 L of cDNA were used for PCR μ
amplification. The reaction mixture was heated at
95 for 4 min and then was subjected to a total
of 35 cycles (1 min at 95 , 1 min at 58 for ER-α
or 62 for ER- , and 1 min at 72 ). The reaction β
was terminated by a final incubation at 72 for
10 min, followed by cooling at 4 . A total of 10
L final PCR product was analyzed by 2% agarose μ
gel electrophoresis, ethidium bromide gel staining,
and examination under ultraviolet light.
All 64 tissue samples were tested for GAPDH
expression and analyzed for AR and ER mRNA
expression. All of the samples that tested negative
for either ER- or ER- were re-tested. GAPDH α β
was amplified as a control for RNA quality. As a
positive control, total RNA from MCF-7 breast
carcinoma cells was reverse-transcribed and am-
plified in parallel with the samples under inves-
tigation. As a negative control, reaction mixtures
without RNA were processed. Deletion mutants
were identified by their different electrophoretic
mobilities and were confirmed by direct se-
quencing after purification (QIAquick Gel Ex-
traction kit; Qiagen, Hilden, Germany).
Immunohistochemical staining
Paraffin sections of liver cancer tissues from
patients were de-paraffinized with xylene and
then rehydrated. Antigen retrieval was performed
by submerging the samples in citrate buffer (pH
6.0), followed by heating the samples in the
microwave. Next, the sections were treated with
3% hydrogen peroxide in methanol to quench
endogenous peroxidase activity and incubated
with 1% bovine serum albumin to block non-
specific binding. A primary anti-androgen recep-
tor antibody (1 : 50 dilution; Cell Signaling, Frank-
furt, Germany) was incubated for 60 min at room
temperature. After washing, the tissue sections
were incubated first with biotinylated anti-rabbit
secondary antibodies and then with streptavidin-
horseradish-peroxidase complexes. The tissue sec-
tions were immersed in 3-amino-9-ethyl carbazol
as a substrate, counterstained with 10% Mayer's
hematoxylin (dehydrated), and mounted with a
crystal mount. For the negative controls, the same
isotype of the non-immune rabbit IgG or the
dilution solution minus the antibody replaced the
primary antibody.
Statistical analysis
The chi-square test was used to test differences
among the groups.
RESULTS
AR expression in HCC patients
AR expression was determined in 64 human
samples. To our surprise, AR was expressed in all
of the examined samples, independent of sex,
viral etiology, and tumor or peritumor tissues
(Fig. 1A, B). To confirm whether AR expression
differed between tumor and paired non-tumor
tissue, the RT-PCR products were loaded together.
No differences in the quantitative expression
between the tumor and peritumor tissues were
observed (Fig. 1C). Five patient blocks (four HBV
patients and one HCV patient) were obtained in
order to confirm the protein levels by immuno-
histochemistry. The results showed that the AR
was expressed in the nuclei of both tumor and
paired non-tumor tissues of HCV and HBV patients
and that no obvious expression differences were
found (Fig. 2). Moreover, of the 32 patients
studied, seven survived longer than five years.Ai Guo Wang, et al.
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ER expression in HCC patients
The expression of ER- was observed in 32 α
patients (Table 3). Wild-type ER- and vER- ex α α -
pression were commonly detected in the samples
and were independent of sex or viral etiology.
However, the expression of vER- was stronger in α
the tumor tissues than in the adjacent peritumor
tissues (Fig. 1A, B). We detected significantly
greater ER- expression in HCV-infected patients β
than in HBV-infected patients (Table 4). Moreover,
ER- expression was not significantly related to β
sex (data not shown). We were unable to detect
the expression of vER- because the desired band β
was too weak to be confirmed by sequencing. We
were unable to confirm this result even though we
used the same RT-PCR primers and conditions
that were used in a previously published paper,
describing vER- detection. β
18,19
DISCUSSION
The screening of gene expression profiles in
Fig. 1. The expression of AR and ER- , - in HCV and α β
HBV patients as determined by RT-PCR analysis. (A)
HCV patient. (B) HBV patient. ER- (1), ER- (2), ER- α α β
(1), ER- (2), and ER- (3) are the ER- , - RT-PCR β β α β
products using different primers (Table 1); S93 and 21 are
patient identification numbers. The arrows show the
vER- bands. (C) AR expression in female and male HCV α
and HBV patients. N, peritumor tissues; T, tumor tissues.
Table 3. Comparison of the Expression of ER- Variant Type by Sex and Causal Agent α
Sex Causal agents
Female Male HCV HBV
Peri-tumoral tissues 9/9 (100%) 19/23 (82.6%) 20/23 (87.0%) 8/9 (88.9%)
HCC tissues 9/9 (100%) 21/23 (91.3%) 21/23 (91.3%) 9/9 (100%)
HCC, hepatocellular carcinoma; HCV, hepatitis C virus, HBV, hepatitis B virus.
Fig. 2. Immunohistochemical staining of AR in hepato-
cellular carcinoma and paired peritumor tissues. AR
protein was present in the nuclei of all normal hepatic and
hepatocellular carcinoma cells. No difference was found in
the expression of AR between tumor and non-tumor
tissues or according to the viral agent. (A) non-tumor
region of an HCV patient: (B) tumor region of a HCV
patient; (C) non-tumor region of a HBV patient; (D) tumor
region of a HBV patient. Magnifications: 200 ×.
A
B
C
A B
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cancer provides useful information for further
research on cancer mechanisms. Sex hormones
affect many functions of the mammalian liver, and
several lines of evidence suggest that sex hormone
receptors may play an important role in liver
tumorigenesis. Recently, investigations in Europe
have examined the expression and activity of sex
hormone receptors in the normal liver and liver
cancer. Useful insights into liver cancer develop-
ment have been obtained from these studies.
Nevertheless, sex hormone receptor expression
has not been investigated in Asian hepatocar-
cinoma patients, which account for 30-40% of all
of the Asian cancer patients. Therefore, we per-
formed this study to confirm that the results seen
in European patients were also found in the Asian
HCC patient population.
This study investigated 32 liver cancer patients.
We could not find any obvious difference in the
AR mRNA and protein expression profiles
between male and female HCV and HBV patients.
Interestingly, our results were very different from
a previous report stating that AR-positive patients
never survive longer than five years,
14 since seven
of the AR-positive patients in our study group
survived for more than five years. Our result
implies that AR expression does not influence
patient survival. At least in Koreans, AR expres-
sion is not significantly correlated with the five-
year survival rate. Moreover, this result may ex-
plain the outcome of a clinical finding that anti-
androgen receptor therapy was ineffective in
treating HCC.
20 Combined, these results imply
that the role of AR in hepatocarcinogenesis still
needs to be elucidated in the Korean population.
For the ER- expression profile, our results α
counter the study by Villa et al.,
15 which found
that vER- is almost always limited to male HCC α
patients and suggested that vER- plays an α
important role in tumorigenesis, as well as in the
male prevalence of HCC. We detected vER- ex α -
pression in both male and female patients. Never-
theless, vER- may play a key role in hepatocar α -
cinogenesis because vER- had a stronger ex α pres-
sion in tumors, compared to peritumor tissues.
Therefore, at least in Koreans, vER- is not a factor α
that is directly related to the male prevalence of
HCC.
Our ER- expression profile results are consis β -
tent with a previous report
17 of a significantly
higher incidence of ER- expression in HCV β
patients, compared to HBV patients. This finding
implies that ER- plays an important role in HCV- β
induced liver disease. However, in our study we
could not confirm the extremely weak vER-β
expression. Furthermore, vER- function remains β
to be elucidated.
In addition, our study was predominantly per-
formed at the mRNA level, using RT-PCR an-
alyses of 32 patients. At the protein level, only AR
expression was examined by the immunohistoche-
mical staining of five patient samples. Although
some of our data counter previous reports which
focused on European patients, our results may
have been influenced by the sensitivity of the
RT-PCR system and the limited number of
patients that we investigated. A larger, more de-
tailed investigation of sex hormone receptor
expression and activity in Asian patients should
be performed.
In conclusion, we found different expression
patterns of AR and ERs in liver cancer samples
from Korean patients, compared to European
patients. Our findings indicate that ER- may β
have important functions related to HCV-induced
liver disease. Furthermore, we found that vER- is α
Table 4. Comparison of the Expression of ER- and ER- in Patients by Causal Agent α β
Patterns of ER expression
HCV patients HBV patients
+ + α β + - α β + + α β + - α β
HCC tissues 22/23 (95.7%)* 1/23 (4.3%) 4/9 (44.4%) 5/9 (55.6%)
*Indicated a significant difference compared with other groups (p < 0.05).
No - - samples were detected. α β
HCC, hepatocellular carcinoma, HCV, hepatitis C virus, HBV, hepatitis C virus.Ai Guo Wang, et al.
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not related to the male prevalence of HCC, but
may function in hepatocarcinogenesis indepen-
dently of sex. Overall, our results indicate that the
AR and ER expression patterns differ according to
race and that the functions of sex hormone
receptors in HCC development must be further
examined.
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